The most recent market research report, titled “Global Biosimilar Monoclonal Antibodies (mAbs) Market 2023” is a carefully executed endeavor that takes into account various aspects and factors affecting the Biosimilar Monoclonal Antibodies (mAbs) industry...

PRESS RELEASE Published May 29, 2023...

PRESS RELEASE Published May 29, 2023...

The most recent market research report, titled “Global Biosimilar Monoclonal Antibodies Market 2023” is a carefully executed endeavor that takes into account various aspects and factors affecting the Biosimilar Monoclonal Antibodies industry and the...

26 MAY 2023 | EU | Celltrion files MAA with EMA for biosimilar to Janssen’s Stelara® (ustekinumab) Korea Biomed has reported that Celltrion filed a marketing authorisation application with the EMA for CT-P43, its biosimilar to Janssen’s Stelara® (ustekinemab).  Based...

Rani Therapeutics Holdings, which is developing a drug-agnostic oral delivery platform, named Kate McKinley chief business officer, the biotherapeutics firm said Wednesday morning. McKinley brings more than 20 years of experience to her role...

Biosimilar market penetration has been slower than that of generics but the market share of biosimilars has grown over time, according to the authors of a study on biosimilar use in the European Union...

Hi, I’m Justina Petrullo for The Center for Biosimilars®, your resource for clinical, regulatory, business, and policy news in the rapidly changing world of biosimilars. Here are the top 5 biosimilar articles for the...

Patents And Generics The pharmaceutical industry is a business dominated by Intellectual Property (IP). Drug patents are a special category in IP laws, with their own set of regulations and duration, different from general...

Daily Brief Health Care: Alfresa Holdings, SD Biosensor, Celltrion …  Smartkarma Source link...